X4 Pharmaceuticals (XFOR) Prepaid Assets (2017 - 2025)
X4 Pharmaceuticals (XFOR) posted Prepaid Assets of $3.5 million for Q4 2025, down 28.39% on a QoQ basis from $4.9 million in Q3 2025, and down 36.88% year-over-year from $5.6 million in Q4 2024.
X4 Pharmaceuticals (XFOR) Prepaid Assets (2017 - 2025) Analysis & Trends
X4 Pharmaceuticals' Prepaid Assets history runs 9 years deep, the most recent figure standing at $3.5 million for Q4 2025.
- Quarterly Prepaid Assets fell 36.88% year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.5 million (down 36.88% YoY) and the FY2025 annual result came in at $3.5 million, down 36.88% from the prior year.
- Prepaid Assets was $3.5 million for Q4 2025 at X4 Pharmaceuticals, down from $4.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.3 million in Q4 2023 and bottomed at $3.5 million in Q4 2025.
- A 5-year average of $4.9 million and a median of $5.0 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2021 — Prepaid Assets soared 45.14% — and 2025, when it plunged 36.88%.
- X4 Pharmaceuticals' Prepaid Assets stood at $5.3 million in 2021, then gained by 8.66% to $5.8 million in 2022, then advanced by 25.68% to $7.3 million in 2023, then retreated by 23.43% to $5.6 million in 2024, then slumped by 36.88% to $3.5 million in 2025.
- Business Quant data shows XFOR's Prepaid Assets at $3.5 million in Q4 2025, $4.9 million in Q3 2025, and $5.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 4.93 Mn |
| Jun 30, 2025 | 4.96 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 5.59 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Jun 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 5.76 Mn |
| Dec 31, 2023 | 7.30 Mn |
| Sep 30, 2023 | 5.80 Mn |
| Jun 30, 2023 | 5.52 Mn |
| Mar 31, 2023 | 4.16 Mn |
| Dec 31, 2022 | 5.81 Mn |
| Sep 30, 2022 | 4.95 Mn |
| Jun 30, 2022 | 4.36 Mn |
| Mar 31, 2022 | 3.59 Mn |
| Dec 31, 2021 | 5.34 Mn |
| Sep 30, 2021 | 3.66 Mn |
| Jun 30, 2021 | 5.16 Mn |
| Mar 31, 2021 | 4.25 Mn |